The GLP-1 Receptor Agonist Market Is Driven By Increasing Prevalence Of Obesity And Diabetes
The global GLP-1 Receptor Agonist Market is estimated to be valued at US$ 12.3 billion in 2023 and is expected to exhibit a CAGR of 17% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.